BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30607019)

  • 1. Recurrent PDGFRB mutations in unicentric Castleman disease.
    Li Z; Lan X; Li C; Zhang Y; Wang Y; Xue W; Lu L; Jin M; Zhou Z; Wang X; Li L; Zhang L; Li X; Fu X; Sun Z; Wu J; Zhang X; Yu H; Nan F; Chang Y; Yan J; Wu X; Wang G; Zhang D; Zhang Y; Young KH; Zhang M
    Leukemia; 2019 Apr; 33(4):1035-1038. PubMed ID: 30607019
    [No Abstract]   [Full Text] [Related]  

  • 2. Whole-Exome Sequencing Reveals the Genomic Profile and IL6ST Variants as a Prognostic Biomarker of Paraneoplastic Pemphigus-Associated Unicentric Castleman Disease.
    Wang S; Wang R; Shang P; Zhu X; Chen X; Zhang G; Wang M
    J Invest Dermatol; 2024 Mar; 144(3):585-592.e1. PubMed ID: 37839777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease.
    Chang KC; Wang YC; Hung LY; Huang WT; Tsou JH; M Jones D; Song HL; Yeh YM; Kao LY; Medeiros LJ
    Mod Pathol; 2014 Jun; 27(6):823-31. PubMed ID: 24201121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-exome sequencing identifies novel somatic alterations associated with outcomes in idiopathic multicentric Castleman disease.
    You L; Lin Q; Zhao J; Shi F; Young KH; Qian W
    Br J Haematol; 2020 Mar; 188(5):e64-e67. PubMed ID: 31863597
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel somatic alterations in unicentric and idiopathic multicentric Castleman disease.
    Goodman AM; Jeong AR; Phillips A; Wang HY; Sokol ES; Cohen PR; Sicklick J; Fajgenbaum DC; Kurzrock R
    Eur J Haematol; 2021 Dec; 107(6):642-649. PubMed ID: 34431136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
    Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
    Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation.
    Takenouchi T; Yamaguchi Y; Tanikawa A; Kosaki R; Okano H; Kosaki K
    J Pediatr; 2015 Feb; 166(2):483-6. PubMed ID: 25454926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myofibromatosis presenting as reticulated vascular changes and subcutaneous atrophy in a patient with somatic mosaicism of PDGFRB mutation.
    Zhong CS; Song H; Weiss A; Tan WH; Coury S; Huang JT
    Br J Dermatol; 2018 Dec; 179(6):1408-1409. PubMed ID: 29999524
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathology of Castleman Disease.
    Wu D; Lim MS; Jaffe ES
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):37-52. PubMed ID: 29157618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of expressivity in PDGFRB-related infantile myofibromatosis: a role for PTPRG?
    Linhares ND; Freire MC; Cardenas RG; Bahia M; Puzenat E; Aubin F; Pena SD
    Genet Mol Res; 2014 Aug; 13(3):6287-92. PubMed ID: 25158255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unicentric Castleman Disease.
    Wong RSM
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):65-73. PubMed ID: 29157620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Castleman Disease.
    Wang W; Medeiros LJ
    Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification.
    Nicolas G; Pottier C; Maltête D; Coutant S; Rovelet-Lecrux A; Legallic S; Rousseau S; Vaschalde Y; Guyant-Maréchal L; Augustin J; Martinaud O; Defebvre L; Krystkowiak P; Pariente J; Clanet M; Labauge P; Ayrignac X; Lefaucheur R; Le Ber I; Frébourg T; Hannequin D; Campion D
    Neurology; 2013 Jan; 80(2):181-7. PubMed ID: 23255827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel PDGFRB sequence variant in a family with a mild form of primary familial brain calcification: a case report and a review of the literature.
    Mathorne SW; Sørensen K; Fagerberg C; Bode M; Hertz JM
    BMC Neurol; 2019 Apr; 19(1):60. PubMed ID: 30979360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.
    Smedile A; Capuano F; Fraticelli S; Lucioni M; La Fianza A
    J Radiol Case Rep; 2019 Mar; 13(3):28-36. PubMed ID: 31565175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?
    Abid MB; Peck R; Abid MA; Al-Sakkaf W; Zhang Y; Dunnill GS; Staines K; Sequeiros IM; Lowry L
    Hematol Oncol; 2018 Feb; 36(1):320-323. PubMed ID: 28401573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unicentric subcutaneous Castleman disease in the upper extremity: a case study and review of the literature.
    Fuse M; Koike T; Nakanishi T; Tanaka T; Namura T; Moritani S; Fujimoto N
    Eur J Dermatol; 2020 Oct; 30(5):617-618. PubMed ID: 33185536
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.
    Agaimy A; Bieg M; Michal M; Geddert H; Märkl B; Seitz J; Moskalev EA; Schlesner M; Metzler M; Hartmann A; Wiemann S; Michal M; Mentzel T; Haller F
    Am J Surg Pathol; 2017 Feb; 41(2):195-203. PubMed ID: 27776010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recurrent PDGFRB mutation causes familial infantile myofibromatosis.
    Cheung YH; Gayden T; Campeau PM; LeDuc CA; Russo D; Nguyen VH; Guo J; Qi M; Guan Y; Albrecht S; Moroz B; Eldin KW; Lu JT; Schwartzentruber J; Malkin D; Berghuis AM; Emil S; Gibbs RA; Burk DL; Vanstone M; Lee BH; Orchard D; Boycott KM; Chung WK; Jabado N
    Am J Hum Genet; 2013 Jun; 92(6):996-1000. PubMed ID: 23731537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Odontogenic myxomas lack PDGFRB mutations reported in myofibromas.
    de Siqueira EC; de Sousa SF; Carlos R; de Andrade BAB; Romañach MJ; Gomez RS; Gomes CC
    J Oral Pathol Med; 2020 Mar; 49(3):278-283. PubMed ID: 32050038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.